These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7955803)

  • 1. A pharmacodynamic study of the alpha 2-adrenergic receptor antagonist ethoxyidazoxan in healthy volunteers.
    Coupland NJ; Bailey JE; Wilson SJ; Potter WZ; Nutt DJ
    Clin Pharmacol Ther; 1994 Oct; 56(4):420-9. PubMed ID: 7955803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of saccadic eye movements in man. 2. Effects of the alpha 2-adrenoceptor ligands idazoxan and clonidine.
    Glue P; White E; Wilson S; Ball DM; Nutt DJ
    Psychopharmacology (Berl); 1991; 105(3):368-73. PubMed ID: 1686814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral pre and postjunctional alpha 2-adrenoceptors in man: studies with RX781094, a selective alpha 2 antagonist.
    Elliott HL; Jones CR; Reid JL
    J Hypertens Suppl; 1983 Dec; 1(2):109-11. PubMed ID: 6152738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alpha adrenoceptor antagonist properties of idazoxan in normal subjects.
    Elliott HL; Jones CR; Vincent J; Lawrie CB; Reid JL
    Clin Pharmacol Ther; 1984 Aug; 36(2):190-6. PubMed ID: 6146423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral glucose metabolic and plasma catecholamine responses to the alpha(2) adrenoceptor antagonist ethoxyidazoxan given to healthy volunteers.
    Schmidt ME; Oshinsky RJ; Kim HG; Schouten JL; Folley BS; Potter WZ
    Psychopharmacology (Berl); 1999 Sep; 146(2):119-27. PubMed ID: 10525746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a peripheral component in the sympatholytic effect of clonidine in rats.
    Brown MJ; Harland D
    Br J Pharmacol; 1984 Nov; 83(3):657-65. PubMed ID: 6150737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a new selective alpha 2-adrenoreceptor antagonist, idazoxan, and the agonist, clonidine, on fasting antroduodenal motility in healthy volunteers.
    Gregersen H; Kraglund K; Rittig S; Tøttrup A
    Aliment Pharmacol Ther; 1989 Oct; 3(5):435-43. PubMed ID: 2577499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of ex vivo platelet aggregation to confirm the in vivo alpha 2-adrenoreceptor antagonist effect of idazoxan in man.
    Muir NC; Doxey JC; Havler ME; Clifford JM
    J Pharmacol Methods; 1987 Sep; 18(2):95-102. PubMed ID: 2887703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of xylazine induced sedation by idazoxan in calves.
    Doherty TJ; Ballinger JA; McDonell WN; Pascoe PJ; Valliant AE
    Can J Vet Res; 1987 Apr; 51(2):244-8. PubMed ID: 2886207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and haemodynamic effects of alpha 2-adrenoceptor stimulation and antagonism in man.
    Brown MJ; Struthers AD; Di Silvio L; Yeo T; Ghatei M; Burrin JM
    Clin Sci (Lond); 1985; 68 Suppl 10():137s-139s. PubMed ID: 2857610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corynanthine inhibits, while idazoxan potentiates, cardiotoxic effects of ouabain.
    Thomas GP
    J Auton Pharmacol; 1995 Apr; 15(2):85-91. PubMed ID: 7615577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological effects and pharmacokinetics of atipamezole, a novel alpha 2-adrenoceptor antagonist--a randomized, double-blind cross-over study in healthy male volunteers.
    Karhuvaara S; Kallio A; Scheinin M; Anttila M; Salonen JS; Scheinin H
    Br J Clin Pharmacol; 1990 Jul; 30(1):97-106. PubMed ID: 1975199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute and chronic administration of idazoxan on blood pressure and plasma catecholamine concentrations of rats.
    Harland D; Brown MJ
    J Pharmacol Exp Ther; 1988 Apr; 245(1):265-73. PubMed ID: 3361445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-HT 958 lowers blood pressure and heart rate in the rat through stimulation of dopamine receptors.
    Brown MJ; Harland D
    Br J Pharmacol; 1986 Feb; 87(2):361-70. PubMed ID: 3006858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of beta 2-adrenoceptor-mediated mechanisms in the cardiovascular responses to alpha 1- and alpha 2-adrenoceptor antagonism in conscious, unrestrained, Long Evans and Brattleboro rats.
    Gardiner SM; Bennett T
    Br J Pharmacol; 1988 Jan; 93(1):9-22. PubMed ID: 2894880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responses to alpha 2-adrenoceptor blockade by idazoxan in healthy male and female volunteers.
    Schmidt ME; Risinger RC; Hauger RL; Schouten JL; Henry M; Potter WZ
    Psychoneuroendocrinology; 1997 Apr; 22(3):177-88. PubMed ID: 9203228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of alpha-2-adrenoceptors in the control of ACTH secretion; interaction with the opioid system.
    al-Damluji S; Bouloux P; White A; Besser M
    Neuroendocrinology; 1990 Jan; 51(1):76-81. PubMed ID: 1968233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of rilmenidine and clonidine on the electroencephalogram, saccadic eye movements, and psychomotor function.
    Harron DW; Hasson B; Regan M; McClelland RJ; King DJ
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S48-54. PubMed ID: 8642806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
    Hernández Hernández R; Angeli-Greaves M; Carvajal AR; Guerrero Pajuelo J; Armas Padilla MC; Armas-Hernández MJ
    Am J Hypertens; 1996 May; 9(5):437-44. PubMed ID: 8735174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.